These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1960544)

  • 1. Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging.
    Mariani C; Farina E; Cappa SF; Anzola GP; Faglia L; Bevilacqua L; Capra R; Mattioli F; Vignolo LA
    J Neurol; 1991 Oct; 238(7):395-400. PubMed ID: 1960544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging.
    Anzola GP; Bevilacqua L; Cappa SF; Capra R; Faglia L; Farina E; Frisoni G; Mariani C; Pasolini MP; Vignolo LA
    J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):142-5. PubMed ID: 2313301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.
    Hohol MJ; Guttmann CR; Orav J; Mackin GA; Kikinis R; Khoury SJ; Jolesz FA; Weiner HL
    Arch Neurol; 1997 Aug; 54(8):1018-25. PubMed ID: 9267977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.
    Piras MR; Magnano I; Canu ED; Paulus KS; Satta WM; Soddu A; Conti M; Achene A; Solinas G; Aiello I
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):878-85. PubMed ID: 12810771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial study of neuropsychological performance and gadolinium-enhanced MRI in MS.
    Mattioli F; Cappa SF; Cominelli C; Capra R; Marcianoc N; Gasparotti R
    Acta Neurol Scand; 1993 Jun; 87(6):465-8. PubMed ID: 8356876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.
    Uher T; Vaneckova M; Sormani MP; Krasensky J; Sobisek L; Dusankova JB; Seidl Z; Havrdova E; Kalincik T; Benedict RH; Horakova D
    Eur J Neurol; 2017 Feb; 24(2):292-301. PubMed ID: 27873386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis.
    Comi G; Filippi M; Martinelli V; Sirabian G; Visciani A; Campi A; Mammi S; Rovaris M; Canal N
    J Neurol Sci; 1993 Apr; 115 Suppl():S66-73. PubMed ID: 8340796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory and learning disturbances in multiple sclerosis. MRI lesions and neuropsychological correlation.
    Izquierdo G; Campoy F; Mir J; Gonzalez M; Martinez-Parra C
    Eur J Radiol; 1991; 13(3):220-4. PubMed ID: 1756751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distributional patterns of multiple sclerosis brain lesions. Magnetic resonance imaging--clinical correlation.
    Gonzalez CF; Swirsky-Sacchetti T; Mitchell D; Lublin FD; Knobler RL; Ehrlich SM
    J Neuroimaging; 1994 Oct; 4(4):188-95. PubMed ID: 7949555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis.
    Tekok-Kilic A; Benedict RH; Zivadinov R
    Expert Rev Neurother; 2006 Mar; 6(3):323-31. PubMed ID: 16533137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes.
    Zipoli V; Goretti B; Hakiki B; Siracusa G; Sorbi S; Portaccio E; Amato MP
    Mult Scler; 2010 Jan; 16(1):62-7. PubMed ID: 19995837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of dementia, neuropsychological and MRI findings in multiple sclerosis.
    Tsolaki M; Drevelegas A; Karachristianou S; Kapinas K; Divanoglou D; Routsonis K
    Dementia; 1994; 5(1):48-52. PubMed ID: 8156087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
    Nunnari D; De Cola MC; D'Aleo G; Rifici C; Russo M; Sessa E; Bramanti P; Marino S
    Biomed Res Int; 2015; 2015():519785. PubMed ID: 25861633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
    Kizlaitienė R; Kaubrys G; Giedraitienė N; Ramanauskas N; Dementavičienė J
    Med Sci Monit; 2017 Feb; 23():588-597. PubMed ID: 28145395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric symptoms and mental changes as major features of multiple sclerosis.
    Sanders EA; van Lieshout HB
    Clin Neurol Neurosurg; 1992; 94 Suppl():S144-6. PubMed ID: 1320493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal associations between MRI and cognitive changes in very early MS.
    Nourbakhsh B; Nunan-Saah J; Maghzi AH; Julian LJ; Spain R; Jin C; Lazar A; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2016 Jan; 5():47-52. PubMed ID: 26856943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study.
    Feinstein A; Kartsounis LD; Miller DH; Youl BD; Ron MA
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):869-76. PubMed ID: 1431949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis].
    Aldrete Cortez VR; Duriez-Sotelo E; Carrillo-Mora P; Pérez-Zuno JA
    Neurologia; 2013 Sep; 28(7):394-9. PubMed ID: 23260448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.